Drugs / Meperidine

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) DEMEROL 1942-11-10 fda.gov

Trials 13 · a red edge is where a trial was stopped

19411942194319441945194619471948194919501951195219531954195519561957195819591960196119621963196419651966196719681969197019711972197319741975197619771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026202720282029
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 21 trial
Phase 2 NCT01236651 Nov 2010 → Apr 2011 Ain Shams University Unknown No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT03260283 Aug 2017 → Nov 2018 Saint Savvas Anticancer Hospital Completed No outcome recorded
Phase 32 trials
Phase 3 NCT05126459 Feb 2022 → Apr 2023 anxiety, dental caries Loma Linda University Completed No outcome recorded
Phase 3 NCT00163553 Dec 2004 → ? sciatica Austin Health Unknown No outcome recorded
Phase 43 trials
Phase 4 NCT05110469 Feb → Jun 2021 benign shuddering attacks AnestesiaR Completed No outcome recorded
Phase 4 NCT02486328 May → Jun 2015 cognitive disorder, digestive system disorder Ufuk University Completed No outcome recorded
Phase 4 NCT00596414 May 2003 → Oct 2005 anxiety, cirrhosis of liver, hepatitis Erasme University Hospital Completed No outcome recorded
Phase not applicable6 trials
NCT07596004 Mar → Jun 2026 overdue Shaheed Mohtarma Benazir Bhutto Institue of Trauma Active not recruiting No outcome recorded
NCT04446715 Oct 2020 → Aug 2021 Makassed General Hospital Unknown No outcome recorded
NCT01741259 Aug 2013 → Apr 2015 Mercy Research Completed No outcome recorded
NCT01840371 Apr 2013 → Mar 2014 Yonsei University Completed No outcome recorded
NCT01547520 Jun 2011 → Feb 2012 Dalin Tzu Chi General Hospital Completed No outcome recorded
NCT00296751 Mar → Dec 2006 Rambam Health Care Campus Completed No outcome recorded
Also used as a comparator or background therapy in 79 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT07711522 Background Aug 2026 → Jul 2027 expected Istanbul Medipol University Hospital Not yet recruiting No outcome recorded
Phase 12 trials
Phase 1 NCT05035407 Background Mar 2022 → Jul 2025 National Cancer Institute (NCI) Terminated No outcome recorded
Phase 1 NCT02867800 Background Jul 2016 → Dec 2021 graft versus host disease, sickle cell disease Monica Bhatia Completed No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT02858310 Background Jan 2017 → Jul 2025 cervical intraepithelial neoplasia, human papilloma virus infection, in situ carcinoma, vulvar neoplasm National Cancer Institute (NCI) Completed No outcome recorded
Phase 210 trials
Phase 2 NCT06326944 Comparator Apr → Sep 2024 Kasr El Aini Hospital Completed No outcome recorded
Phase 2 NCT03456817 Background Jul 2020 → May 2025 graft versus host disease AHS Cancer Control Alberta Terminated No outcome recorded
Phase 2 NCT03968146 Background Jun → Nov 2019 idiopathic scoliosis Kasr El Aini Hospital Completed No outcome recorded
Phase 2 NCT02441673 Comparator Oct 2018 → Jan 2019 benign shuddering attacks Lagos State Health Service Commission Unknown No outcome recorded
Phase 2 NCT02619019 Comparator Nov 2015 → Jun 2016 benign shuddering attacks Assiut University Completed No outcome recorded
Phase 2/34 trials
Phase 2/3 NCT06082076 Comparator Nov 2023 → Nov 2024 Assiut University Unknown No outcome recorded
Phase 2/3 NCT03167905 Comparator Jun 2017 → Jul 2021 overdue postpartum depression KK Women's and Children's Hospital Active not recruiting No outcome recorded
Phase 2/3 NCT03652116 Comparator Apr 2017 → Jun 2018 obstetric disorder Ain Shams University Completed No outcome recorded
Phase 2/3 NCT02707250 Comparator Mar 2015 → Feb 2016 Iuliu Hatieganu University of Medicine and Pharmacy Unknown No outcome recorded
Phase 36 trials
Phase 3 NCT07299630 Background Dec 2025 → May 2026 Ain Shams University Completed No outcome recorded
Phase 3 NCT06775431 Comparator Dec 2024 → Feb 2025 overdue Alexandria University Recruiting No outcome recorded
Phase 3 NCT03115047 Comparator May 2017 → Aug 2020 University of Montreal Hospital Centre (CHUM) Completed No outcome recorded
Phase 3 NCT04686058 Comparator Mar → Dec 2014 Universiti Kebangsaan Malaysia Medical Centre Completed No outcome recorded
Phase 3 NCT01833312 Background Jul 2013 → Jul 2018 ischemic stroke University of Erlangen-Nürnberg Medical School Terminated No outcome recorded
Phase 421 trials
Phase 4 NCT06736938 Comparator Apr 2025 → Apr 2027 expected Fondazione Andrea Cesalpino Arezzo ONLUS Not yet recruiting No outcome recorded
Phase 4 NCT06172920 Comparator Dec 2023 → Nov 2024 respiratory system disorder Baskent University Unknown No outcome recorded
Phase 4 NCT05284409 Comparator Jul → Sep 2022 benign shuddering attacks Ain Shams University Completed No outcome recorded
Phase 4 NCT05386121 Comparator May → Sep 2022 Cairo University Unknown No outcome recorded
Phase 4 NCT05303311 Comparator Jan 2022 → Jan 2024 Zagazig University Completed No outcome recorded
Phase not applicable34 trials
NCT07278050 Comparator Jan → Sep 2026 expected Medipol University Recruiting No outcome recorded
NCT07264309 Comparator Nov 2025 → Dec 2026 expected Zohar Nachum Recruiting No outcome recorded
NCT06962085 Comparator Sep 2025 → Jan 2026 Adiyaman University Completed No outcome recorded
NCT06866054 Background Apr → Aug 2025 overdue arthropathy Kahramanmaras Sutcu Imam University Recruiting No outcome recorded
NCT05270434 Background Mar → Oct 2025 chronic pancreatitis Changhai Hospital Completed No outcome recorded

Evidence & citations 9 cited values

Every value below carries the sentence it was read from. 92 sources stand behind the page.

FieldValueCited text
Known as meperidine “If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05904912
45

“If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT06546839

“If the NRS score is ≥ 4, 0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05972122

“If the NRS score is ≥ 4, 0.5 mg kg-1 IV meperidine will be administered as a rescue analgesic.” NCT07278050

“Group P (n =80) will receive pethidine (meperidine) 0.5 mg/kg i.v. (Ampoules of 50 mg/1 ml).” NCT06627816

“Intravenous meperidine administration at 0.5 mg / kg rescue analgesia was determined” NCT03413163

“Hydroxyzine (1.5- 2mg/kg) + Meperidine (1.5 -2 mg/kg) + Midazolam (0.5- 0.75 mg/kg)” NCT05126459

“If the VAS score will be ≥ 4, 0,5 mg/kg-1 meperidine IV will be administered.” NCT05621161

Meperidine 25-50 mg IVPB every 4 hours will be given as needed for rigors.” NCT03456817

“0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05972083

“0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT06866054

“0.5 mg kg-1 iv meperidine will be administered as a rescue analgesic.” NCT05566561

“Patients are receiving meperidine under thoracic surgery” NCT06172920

“Propofol Meperidine : 25 mg IV just before procedure” NCT01840371

“Pethidine (meperidine) is a unique opioid.” NCT05303311

NCT01693185

NCT04446715

NCT01236651

NCT01229527

NCT01709422

NCT02684942

NCT03167905

NCT07711522

NCT01547520

NCT01948921

NCT02625181

NCT02783508

NCT00296751

NCT00848861

NCT05035407

NCT05110469

NCT02027311

NCT00937924

NCT04735965

NCT01555671

NCT02393144

NCT06082076

NCT06962085

NCT02867800

NCT03115047

NCT01741259

NCT02475824

NCT04068948

NCT02486328

NCT02858310

NCT01394731

Known as Demerol ClinicalTrials.gov intervention name — accepted as the source's own label NCT01997788
Known as Dexmeditomidine ClinicalTrials.gov intervention name — accepted as the source's own label NCT07596004
Known as pethidine “Group P (n =80) will receive pethidine (meperidine) 0.5 mg/kg i.v. (Ampoules of 50 mg/1 ml).” NCT06627816
44

“fentanyl based patient-controlled analgesia + additional pethidine for postoperative 48 hour” NCT02012244

“intravenous paracetamol( 1gram ) and pethidine IV (50 mg ) will be added when needed.” NCT03422354

“Postoperatively pethidine 50 mg IV will be administered for VAS score greater than 4” NCT07299630

“The forth group consisted of 25 participants receiving 100 mg pethidine.” NCT01993589

“then intravenous pethidine till 48 hours after surgery” NCT03866733

“Group P received pethidine 50 mg IV.” NCT03780556

“intravenous pethidine 0.25 mg/kg” NCT04133571

“"Meperidine" (pethidine®)” NCT02475824

NCT05386121

NCT06775431

NCT02179294

NCT03260283

NCT02494180

NCT02037802

NCT07264309

NCT05696886

NCT02382432

NCT02557087

NCT02578251

NCT00566683

NCT02619019

NCT02441673

NCT02971475

NCT02549118

NCT02707250

NCT05303311

NCT02858622

NCT03032458

NCT06326944

NCT00596414

NCT05284409

NCT03968146

NCT06736938

NCT02039453

NCT05270434

NCT00163553

NCT01833312

NCT04744727

NCT02016976

NCT02493192

NCT02651792

NCT04719507

NCT03652116

NCT04686058

Known as pethidine HCL “Meperidine (50mg. 25mg for patients aged ≥70 years; pethidine HCL, Hana Pharm Co., Seoul, Republic of Korea).” NCT02475824
Known as Pethidine Hydrochloride Pethidine Hydrochloride 50 Mg/mL Solution for Injection” NCT06775431
2

NCT01858090

NCT01558622

Action Activate “Pethidine is one of the most frequently used opiate agonists.” NCT02783508
Modality Small molecule “synthetic opioid analgesic” NCT01558622
Route Other “continuous infusion of epidural pethidine through a surgically-placed catheter” NCT00163553